Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CERE is no longer listed, so this page shows Q2 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 231
- +23 vs. Q1 2024
- Shares held
- 156.9M
- +348.7K (+0.2%) vs. Q1 2024
- Total value
- $6.42B
- −$201.1M (−3.0%) vs. Q1 2024
- New holders
- 43
- 82 more added
- Sold out
- 20
- 69 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $1.16K |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 231 | $6.42B |
| Q1 2024 | 210 | $6.67B |
| Q4 2023 | 195 | $6.61B |
| Q3 2023 | 119 | $3.07B |
| Q2 2023 | 125 | $4.41B |
| Q1 2023 | 119 | $3.30B |
| Q4 2022 | 125 | $4.23B |
| Q3 2022 | 115 | $3.76B |
| Q2 2022 | 109 | $3.28B |
| Q1 2022 | 107 | $4.27B |
| Q4 2021 | 107 | $3.84B |
| Q3 2021 | 94 | $3.51B |
| Q2 2021 | 82 | $2.65B |
| Q1 2021 | 62 | $1.37B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 517 | $21.1K | 0.00% | 00.0% | Unchanged |
| HM Payson & Co | 500 | $20.4K | 0.00% | 00.0% | Unchanged |
| Riverview Trust Co | 385 | $15.7K | 0.01% | 00.0% | Unchanged |
| Comerica Bank | 378 | $15.4K | 0.00% | −365−49.1% | Reduced |
| Covestor Ltd | 287 | $12.0K | 0.01% | +1+0.3% | Added |
| Beaird Harris Wealth Management, LLC | 265 | $10.8K | 0.00% | +265 | New |
| CWM, LLC | 225 | $9.00K | 0.00% | +21+10.3% | Added |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 211 | $8.63K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 210 | $8.59K | 0.00% | 00.0% | Unchanged |
| Scarborough Advisors, LLC | 200 | $8.18K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 175 | $7.16K | 0.00% | +95+118.8% | Added |
| Exchange Traded Concepts, LLC | 156 | $6.38K | 0.00% | +56+56.0% | Added |
| Ci Investments Inc. | 139 | $6.00K | 0.00% | −8−5.4% | Reduced |
| Smartleaf Asset Management LLC | 145 | $5.87K | 0.00% | +145 | New |
| Ronald Blue Trust, Inc. | 119 | $5.03K | 0.00% | +23+24.0% | Added |
| Quadrant Capital Group LLC | 120 | $4.91K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 111 | $4.76K | 0.00% | +47+73.4% | Added |
| Anchor Investment Management, LLC | 100 | $4.09K | 0.00% | 00.0% | Unchanged |
| Itau Unibanco Holding S.A. | 100 | $4.09K | 0.00% | +100 | New |
| EverSource Wealth Advisors, LLC | 79 | $3.55K | 0.00% | +7+9.7% | Added |
| TD Private Client Wealth LLC | 78 | $3.19K | 0.00% | +78 | New |
| Benjamin F. Edwards & Company, Inc. | 80 | $3.00K | 0.00% | −102−56.0% | Reduced |
| Farther Finance Advisors, LLC | 43 | $1.78K | 0.00% | +40+1,333.3% | Added |
| Rothschild Investment LLC | 25 | $1.02K | 0.00% | +20+400.0% | Added |
| Continuum Advisory, LLC | 17 | $695 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 16 | $654 | 0.00% | +4+33.3% | Added |
| Global Retirement Partners, LLC | 12 | $491 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 9 | $372 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 4 | $164 | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 4 | $164 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 11 | $0 | 0.00% | 00.0% | Unchanged |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −564,044−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −547,946−100.0% | Sold out |
| Capital International Investors | 0 | $0 | 0.00% | −253,495−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −128,068−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −35,294−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −31,526−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −19,700−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| Black Maple Capital Management LP | 0 | $0 | 0.00% | −15,702−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −13,507−100.0% | Sold out |
| Greenland Capital Management LP | 0 | $0 | 0.00% | −8,960−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −8,354−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −7,236−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −5,099−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −5,001−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,833−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −423−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Segantii Capital Management Ltd | – | – | – | – | Not filed |
| Credit Suisse AG | – | – | – | – | Not filed |